BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31892312)

  • 1. Pathogenetic approach to the treatment of functional disorders of the gastrointestinal tract and their intersection: results of the Russian observation retrospective program COMFORT.
    Ivashkin VT; Poluektova EA; Glazunov AB; Putilovskiy MA; Epstein OI
    BMC Gastroenterol; 2019 Dec; 20(1):2. PubMed ID: 31892312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy of Kolofort for the treatment of patients with irritable bowel syndrome].
    Tsukanov VV; Rzhavicheva OS; Vasjutin AV; Dunaevskaja OV; Tonkih JL; Bronnikova EP
    Ter Arkh; 2016; 88(8):40-45. PubMed ID: 27636926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors.
    von Wulffen M; Talley NJ; Hammer J; McMaster J; Rich G; Shah A; Koloski N; Kendall BJ; Jones M; Holtmann G
    Dig Dis Sci; 2019 Feb; 64(2):480-486. PubMed ID: 30368683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
    Nam K; Kim N; Song HJ; Baik GH; Choi SC; Kim HJ; Lee JY; Park KS; Park SY; Park SJ
    J Gastroenterol; 2021 Jun; 56(6):537-546. PubMed ID: 33687537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impacts of the COVID-19 pandemic on functional dyspepsia and irritable bowel syndrome: A population-based survey.
    Oshima T; Siah KTH; Yoshimoto T; Miura K; Tomita T; Fukui H; Miwa H
    J Gastroenterol Hepatol; 2021 Jul; 36(7):1820-1827. PubMed ID: 33197076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overlap between irritable bowel syndrome and functional dyspepsia including subtype analyses.
    Choi YJ; Kim N; Yoon H; Shin CM; Park YS; Kim JW; Kim YS; Lee DH; Jung HC
    J Gastroenterol Hepatol; 2017 Sep; 32(9):1553-1561. PubMed ID: 28160607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical overlap between functional dyspepsia and irritable bowel syndrome based on Rome III criteria.
    Wang A; Liao X; Xiong L; Peng S; Xiao Y; Liu S; Hu P; Chen M
    BMC Gastroenterol; 2008 Sep; 8():43. PubMed ID: 18808723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A correlation study between diarrhea-predominant irritable bowel syndrome complicated functional dyspepsia patients of Gan-stagnation Pi-deficiency syndrome and gastrointestinal hormones].
    Zhao L; Song W; Zhu P; Zhang Y; Bu P
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Oct; 34(10):1168-72. PubMed ID: 25509256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concomitant Irritable Bowel Syndrome Does Not Influence the Response to Antimicrobial Therapy in Patients with Functional Dyspepsia.
    Shah A; Gurusamy SR; Hansen T; Callaghan G; Talley NJ; Koloski N; Walker MM; Jones MP; Morrison M; Holtmann GJ
    Dig Dis Sci; 2022 Jun; 67(6):2299-2309. PubMed ID: 34392491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised clinical trial: sustained response to PPI treatment of symptoms resembling functional dyspepsia and irritable bowel syndrome in patients suffering from an overlap with erosive gastro-oesophageal reflux disease.
    Mönnikes H; Schwan T; van Rensburg C; Straszak A; Theek C; Sander P; Lühmann R
    Aliment Pharmacol Ther; 2012 Jun; 35(11):1279-89. PubMed ID: 22486552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
    Kotani S; Fukuba N; Kawashima K; Mishima Y; Sonoyama H; Okimoto E; Tada Y; Oka A; Tamagawa Y; Oshima N; Mishiro T; Tobita H; Shibagaki K; Moriyama I; Ishimura N; Kushiyama Y; Fujishiro H; Ishihara S
    Scand J Gastroenterol; 2020 May; 55(5):560-564. PubMed ID: 32412797
    [No Abstract]   [Full Text] [Related]  

  • 12. Psychopathological features of irritable bowel syndrome patients with and without functional dyspepsia: a cross sectional study.
    Piacentino D; Cantarini R; Alfonsi M; Badiali D; Pallotta N; Biondi M; Corazziari ES
    BMC Gastroenterol; 2011 Aug; 11():94. PubMed ID: 21871075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of overlapping functional dyspepsia, belching disorders and functional heartburn on anxiety, depression and quality of life of Chinese patients with irritable bowel syndrome.
    Yao X; Yang Y; Zhang S; Shi Y; Zhang Q; Wang Y
    BMC Gastroenterol; 2020 Jul; 20(1):209. PubMed ID: 32631285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spectra of functional gastrointestinal disorders diagnosed by Rome III integrative questionnaire in a Japanese outpatient office and the impact of overlapping.
    Nakajima S; Takahashi K; Sato J; Fukuda M; Yamamoto K; Inoue T; Okumura Y; Fujiyama Y
    J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S138-43. PubMed ID: 20586856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional Dyspepsia and Severity of Psychologic Symptoms Associate With Postprandial Symptoms in Patients With Irritable Bowel Syndrome.
    Pohl D; Van Oudenhove L; Törnblom H; Le Nevé B; Tack J; Simrén M
    Clin Gastroenterol Hepatol; 2018 Nov; 16(11):1745-1753.e1. PubMed ID: 29702295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of competing diagnostic models of functional gastrointestinal disorders related to pain in children.
    Schurman JV; Karazsia BT; Friesen CA
    Neurogastroenterol Motil; 2017 Nov; 29(11):. PubMed ID: 28656703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of coexisting irritable bowel syndrome on symptoms and pathophysiological mechanisms in functional dyspepsia.
    Corsetti M; Caenepeel P; Fischler B; Janssens J; Tack J
    Am J Gastroenterol; 2004 Jun; 99(6):1152-9. PubMed ID: 15180740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of coexisting irritable bowel syndrome and non-erosive reflux disease on postprandial abdominal fullness and sleep disorders in functional dyspepsia.
    Futagami S; Yamawaki H; Shimpuku M; Izumi N; Wakabayashi T; Kodaka Y; Nagoya H; Shindo T; Kawagoe T; Sakamoto C
    J Nippon Med Sch; 2013; 80(5):362-70. PubMed ID: 24189354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
    De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
    Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of irritable bowel syndrome and functional dyspepsia, overlapping symptoms, and associated factors in a general population of Bangladesh.
    Perveen I; Rahman MM; Saha M; Rahman MM; Hasan MQ
    Indian J Gastroenterol; 2014 May; 33(3):265-73. PubMed ID: 24664445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.